News

Colleen Goggins joins QuintilesIMS Board of Directors

Thursday, July 27, 2017

QuintilesIMS, a provider of information, technology solutions and contract research services to the life sciences industry, announced the appointment of Colleen Goggins to its board of directors, effective today. A senior executive at Johnson & Johnson for more than three decades, Goggins retired in 2011 after serving ten years on J&J’s Executive Committee and as the Worldwide Chairman of its Consumer Group. Under her leadership, the J&J global personal and healthcare portfolio, comprising many of the most recognized consumer brands and medicines in the world, grew to more than $16 billion in annual revenue.

[Read More]

The All of Us Research Program announces first community partner awards

Tuesday, July 25, 2017

The National Institutes of Health announced its first four community partner awards to begin building a national network of trusted leaders to motivate diverse communities to join the All of Us Research Program, part of the Precision Medicine Initiative. This initial group of awardees will receive a combined $1.7 million this fiscal year, with future support planned pending the availability of funds. These awardees will raise awareness about the program among seniors, Hispanics and Latinos, African Americans and the LGBTQ community, to complement other outreach efforts of the program. NIH anticipates making additional funding awards for community partners in the future, drawing on the lessons learned from this initial set of awardees.

[Read More]

Survey: Discussions about clinical trials should be part of standard of care

Tuesday, July 25, 2017

An overwhelming majority of Americans (86%) agree that healthcare professionals should discuss clinical trials with patients diagnosed with a disease as part of their standard of care, according to a new national public opinion survey commissioned by Research!America. And three-quarters of respondents (75%) agree that taking part in clinical trials is as valuable to our health care system as giving blood. But Americans are split on whether it’s important for everyone to take part in a clinical trial if they are asked—44% agree while 45% disagree and 12% are not sure. A higher percentage (74%) said they would participate if they are asked by someone they trust.

[Read More]

WHO urges action against HIV drug resistance threat

Tuesday, July 25, 2017

WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.

[Read More]

Vaxil BioTherapeutics appoints Dr. Terry Plasse chief medical officer

Tuesday, July 25, 2017

Vaxil Bio, an Israeli-Canadian biotech developing innovative immunotherapy treatments for cancer, announced the appointment of Dr. Terry Plasse as its chief medical officer, responsible for the company’s clinical program surrounding its drug candidate, ImMucin. Dr. Plasse brings 30 years of clinical development experience, including advancing products from IND through to commercially marketed treatments for several big-pharma companies.

[Read More]